Cardiology

Evinacumab cuts cholesterol levels by half in patients with HoFH

The investigational drug evinacumab reduced low-density lipoprotein (LDL) cholesterol to near-normal levels among patients with a rare cholesterol disorder, meeting the primary endpoint in the first randomized placebo-controlled ...

Cardiology

Many with atherosclerotic CVD not meeting LDL-C goals

(HealthDay)—A high proportion of patients with atherosclerotic cardiovascular disease (ASCVD) do not achieve recommended low-density lipoprotein cholesterol (LDL-C) goals, according to a study presented at the annual meeting ...

Cardiology

It is never too late to start statins for clogged leg arteries

Statins are linked with reduced mortality in patients with peripheral arterial disease, even when started late after diagnosis, reports a study presented today at ESC Congress 2019 together with the World Congress of Cardiology. ...

page 8 from 22